Skip to content

13F-HR filed by JGP Global Gestao de Recursos Ltda.

JGP Global Gestao de Recursos Ltda. filed this 13F-HR for the quarter ended 2017-03-31, filed 2017-05-09, with 16 holding rows worth $120,385,000.

Accession
0001172661-17-000966
Filed
2017-05-09
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2017

A holdings report, 16 entries on the cover page, a total value of $120,385,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $120,385,000 with VALUE read as thousands by filing date, 13F file number 028-16384. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS200,000$47,148,000thousands by filing dateput
KRAFT HEINZ CO COM500754106Stock506,888$46,030,000thousands by filing date
ANHEUSER BUSCH INBEV SA NV SPONSORED ADR03524A108ADR109,700$12,041,000thousands by filing date
ISHARES INC MSCI BRAZIL ETF464286400MSCI BRAZIL ETF100,000$3,746,000thousands by filing datecall
INCYTE CORP COM45337C102Stock15,188$2,030,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM21,624$1,898,000thousands by filing date
CELGENE CORP151020104COM14,131$1,758,000thousands by filing date
UnitedHealth Group Inc91324P102COM9,772$1,603,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM9,245$1,121,000thousands by filing date
Eli Lilly and Company532457108COM7,969$670,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock1,179$457,000thousands by filing date
TESARO INC881569107COM2,860$440,000thousands by filing date
SEATTLE GENETICS INC812578102COM6,433$404,000thousands by filing date
ISHARES INC MSCI BRAZIL ETF464286400MSCI BRAZIL ETF10,000$375,000thousands by filing dateput
Vertex Pharmaceuticals Incorporated92532F100COM3,339$365,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM6,903$299,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-17-000966this filing2017-05-09acceptance time not in the bulk data set